This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: River Stone Biotech LLC. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Marco Santella: Innovator in Pharmaceutical Chemistry
Introduction
Marco Santella is a notable inventor based in København, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of important compounds. His work has implications for the development of medications that can improve patient outcomes.
Latest Patents
Marco Santella holds a patent for the preparation of buprenorphine. This patent discloses methods for preparing buprenorphine from compounds such as nororipavine and northebaine. This innovation is crucial for the pharmaceutical industry, as buprenorphine is widely used in pain management and addiction treatment.
Career Highlights
Marco is currently employed at River Stone Biotech LLC, where he continues to advance his research and development efforts. His expertise in pharmaceutical chemistry has positioned him as a valuable asset to his company and the broader scientific community.
Collaborations
Marco has collaborated with notable colleagues, including Patrick Roussel and Jimmy Van Wiltenburg. These partnerships have fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
Marco Santella's contributions to pharmaceutical chemistry, particularly through his patent on buprenorphine preparation, highlight his role as an innovator in the industry. His work continues to influence the development of important medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile